Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer

Although research into immunotherapy is growing, its use in the treatment of breast cancer remains limited. Thus, identification and evaluation of prognostic biomarkers of tissue microenvironments will reveal new immune-based therapeutic strategies for breast cancer. Using an in silico bioinformatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Jian, Liu, Yu, Hu, Jiliang, Lu, Li, Dou, Zhen, Dai, Haiming, Wang, Hongzhi, Yang, Wulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928373/
https://www.ncbi.nlm.nih.gov/pubmed/33679387
http://dx.doi.org/10.3389/fphar.2020.593247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928373/
https://www.ncbi.nlm.nih.gov/pubmed/33679387
http://dx.doi.org/10.3389/fphar.2020.593247

Ejemplares similares